Compliance with Regulation 21 CFR Part 11 on Electronic Records and Electronic Signatures (ESR01A)
 | Self-paced Training: 24/7 access to course. Enrollment Period: 3 months.  Catalog: Electronic Records.Demonstration: Try one of our FREE courses. Certificate: View sample certificate. PRICE: USD $225.00 
|
 Training Program: Compliance with Regulation 21 CFR Part 11 on Electronic Records and Electronic SignaturesTraining Provided By: BioPharma Institute Website: https://www.biopharmainstitute.com Availability: Immediately available upon ordering. Description: Online training with immediate access upon enrollment.  Part 11 of Title 21 of the US Code of Federal Regulations (21CFR11) sets out requirements that computer systems must meet to satisfy the Food and Drug Administration (FDA), and to assure that electronic records and electronic signatures provided by those systems are trustworthy and reliable to the same extent as paper counterparts. The regulation sets out controls and procedures which need to be established and followed for relevant computer systems in FDA-regulated environments. An FDA-regulated environment is a 'GxP' environment operated by an organisation involved in activities leading to the marketing of drugs or medical devices in the USA; examples are drug manufacturing sites, medical device manufacturing sites, analytical laboratories, clinical investigational sites, and nonclinical study laboratories. 21 CFR Part 11 applies to records that are required to be submitted to the FDA, or that are subject to FDA inspection, and that are in electronic form- that is, as computer files. It applies to all computer systems used to create, modify, maintain, archive, retrieve, or transmit such records- from a humble spreadsheet program to a complex information management system. Companies that market or intend to apply for approval to market drugs or medical devices in the USA must comply with 21 CFR Part 11, whether or not they are based in the USA. Suppliers to such companies of materials, equipment, or data that are subject to FDA regulation must also comply. Benefits of Getting Certified at BioPharma Institute For over two decades, BioPharma Institute has been providing comprehensive and flexible online training solutions for thousands of organizations across the pharmaceutical, healthcare, and biotechnology industries. Our eLearning solutions make it extremely convenient for professionals to upgrade their skills within a flexible schedule, and without having to allocate time to conduct or attend live training programs. Each course is designed to engage students via an active learning process with tools such as live and recorded seminars, online books, high quality animations, and more. You can rest assured that we cater to both small-scale and large-scale training requests as well. Have Questions? Should you have any particular question about this course, you can call us at (888) 424-6576 or send us an email at support@biopharmainstitute.com for more information. Certification Requirements: Students must view the entire program and successfully pass an online, multiple-choice final assessment with >80% passing grade within a 90 day period of time (180 days for Professional Certification Programs). Certificate is accessible in PDF format immediately after satisfying requirements. The Compliance with Regulation 21 CFR Part 11 on Electronic Records and Electronic Signatures course is found in the following professional certification program(s):
|
COURSE OUTLINE:Course Overview- An outline of the course scope and objectives, and notes on terminology. 21 CFR Part 11 and its scope- We define regulation 21 CFR Part 11, explain its purpose, and set out criteria for identifying the environments, computer systems, electronic records, and electronic signatures to which it applies. We describe how underlying legal requirements are specified by predicate rules. We point out that it is not the type of computer system that determines whether Part 11 applies, but the use to which the system is put. Finally, we introduce the regulation's distinction between closed and open systems. Procedures and controls- We describe the procedures and controls that need to be established and followed to comply with Part 11. We identify those for which the FDA exercises enforcement discretion. We give examples of open systems and outline additional procedures and controls required for them. Electronic signatures- We set out Part 11's requirements for electronic signatures. We specify the information to be provided and we outline constraints on the way signatures are linked to records. We emphasize the importance of uniqueness of signatures and verification of the identity of signatories. We mention the need for one-off certification with the FDA. We outline components of non-biometric and biometric signatures. Finally, we set out procedures and controls required for user names and passwords. FDA enforcement discretion- We describe the FDA's narrow interpretation of Part 11, and its effect on the need to comply with some of the regulation's provisions. We discuss the latest relevant FDA guidance for industry and the effect of the agency's interpretation on its enforcement of compliance with requirements for validation, audit trails, record retention, and record copying. We also specify the exemption for legacy computer systems. Assessment- Multiple-choice mastery assessment. | COURSE OBJECTIVES:Who will benefit from this module? This module provides essential training for all personnel who use computer systems in GxP environments. Learning objectives: --Define regulation 21CFR11 and explain its context and purpose --Specify criteria to determine which environments, computer systems, electronic records, and electronic signatures must comply with the regulation --Describe procedures and controls required by the regulation for electronic records and electronic signatures --Describe the consequences of the FDA's discretion in enforcing compliance with some of the provisions of the regulation | |
Online Training Program Benefits:
- Immediate access to training: Instructions, username, password and receipt of payment emailed instantly upon online enrollment
- Optimized for learning: Courses include voice-overs, easy navigation, progress checks, and high-quality animations to increase retention of subject matter
- Self-paced courses: 24/7 access to individual courses for 90 days; and 180 days for professional certification programs
- Flexible final assessments: Tests include multiple-choice questions and can be taken repeatedly until a passing score is achieved
- Direct access to certificates: Documentation instantly available once course requirements have been fulfilled
- Verification of training: Certificates can be verified online, and electronic badges are issued for all Professional Certification programs
- Tuition reimbursement: Some employers may reimburse for training expenses; check on your company's requirements
- Purchase orders (POs) accepted: If POs are required, request an invoice to start the procurement process
- Corporate LMS compatibility: All courses are SCORM compliant and can be delivered from most corporate Learning Management Systems
- Secure and safe access: Website and LMS offer an encrypted connection with firewall protection and daily scans for optimal level of security and performance
- Career advancement: Professional certifications could be helpful for those seeking new careers or transitioning to different positions within their organization
For more information on the BioPharma Institute's training programs, or to suggest a course, please complete the form located below. Alternatively, you may call toll free in the US: (888) 4-BIO-LRN, international callers can dial (201) 301-8370, or email Support@BioPharmaInstitute.com.
